Improved Discount Helps Lilly Secure English Funding For Verzenios

CDK4/6 Inhibitor Ibrance Has Not Yet Been Reappraised by NICE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".